Krawczyk M, Fidyt K, Fernandez-Fuentes N, Winiarski T, Pepek M, Bousquets-Muñoz P, Puente XS, Gutiérrez-Fernández A, Davis J, Owczarek D, Graczyk-Jarzynka A, Sanz-Galarreta P, Menendez P, Szumera-Ciećkiewicz A, Benard E, Wälchli S, Thomas-Tikhonenko A, Pérez-García VM, Galán-Gómez V, Escudero López A, Delgado EI, Minguillón J, Pérez-Martínez A, Winiarska M(2026) Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy Leukemia(in press) DOI 10.1038/s41375-026-03081-3, PubMed 42660975
Rovesti G, Woodbridge AF, Yao H, Pancaldi A, Chiavelli C, Gatto F, Sandvick U, Sällberg M, Fuxe J, Dominici M, Grönlund H, Nilsson OB, Nascimento Silva D, Pasetto A(2026) Immunogenomic profiling reveals targets for gene therapy in pediatric brain tumors Neurooncol Adv, 8(1), vdag193 DOI 10.1093/noajnl/vdag193, PubMed 42592420
Ailte I, Chauhan SK, Prasmickaite L, Bassarova AV, Poissonnier A, Feenstra M, Nyakas M, Johannessen B, Ryder T, Hermann R, Frich L, Holth A, Inderberg EM, Jespersen H, Flørenes VA, Kyte JA, Mælandsmo GM, Egeland EV(2026) CD38hiCD19dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade Front Oncol, 16, 1815008 DOI 10.3389/fonc.2026.1815008, PubMed 42158424
